๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-11-25

The CARDIO-TTRansform Scintigraphy Sub-study (NCT06073587)

CARDIO-TTRansform ION-682884-CS2-Scintigraphy Sub-study

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Ionis Pharmaceuticals, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this study is to examine the changes in amyloid myocardial burden in a subset of the population participating in the ION682884-CS2 (NCT04136171) study, up to 150 participants, after treatment with eplontersen or placebo based on scintigraphy scans performed at Week 140 using the Perugini grade score method.

Who can join: Review the eligibility criteria below.

Location: Columbia University Irving Medical Center โ€” New York, New York

Age range: 18 Years to 90 Years

๐Ÿงช Interventions in This Study

  • Scintigraphy scan (DIAGNOSTIC_TEST)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (5 Sites)

  • Columbia University Irving Medical Center โ€” New York, New York
  • Duke University Medical Center โ€” Durham, North Carolina
  • Cleveland Clinic Main Campus โ€” Cleveland, Ohio
  • Oregon Health and Science University โ€” Portland, Oregon
  • Hospital Universitario Puerta de Hierro โ€” Majadahonda,

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—